Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_assertion type Assertion NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_head.
- NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_assertion description "[IRS1 G972R GR/RR genotypes were associated with a 2.8-fold increased risk for prostate cancer and also associated with a more advanced Gleason score and AJCC stage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_provenance.
- NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_assertion evidence source_evidence_literature NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_provenance.
- NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_assertion SIO_000772 15678496 NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_provenance.
- NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_assertion wasDerivedFrom lhgdn-20090331 NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_provenance.
- NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_assertion wasGeneratedBy ECO_0000203 NP166593.RA4F3CLJqS_bBi8nZCE5a7NrRvNFPr4rTPUI6jtMe3Dsc130_provenance.